KOHEI OKADA

Papers

Total Citations

H-Index

About

Kohei Okada is a dedicated urological researcher whose work focuses on improving outcomes for prostate cancer patients, particularly those experiencing biochemical recurrence after surgery. His research centers on identifying predictive factors for prostate-specific antigen (PSA) recurrence following radical prostatectomy, with a special emphasis on optimizing salvage radiotherapy strategies. Okada’s major contribution lies in elucidating the prognostic significance of histopathological patterns—most notably, his 2024 study demonstrated that the cribriform pattern is a powerful predictive factor for PSA recurrence in patients receiving radiotherapy after prostatectomy. This finding has direct clinical implications, helping to risk-stratify patients and tailor post-surgical treatment decisions. While his most-cited paper has garnered 2 citations to date, its recency signals growing interest in this precision oncology approach. Okada’s work bridges surgical pathology and radiation oncology, offering actionable insights for clinicians managing high-risk prostate cancer patients. His research is particularly valuable for urologists and radiation oncologists seeking evidence-based criteria to guide salvage therapy, ultimately aiming to reduce recurrence rates and improve long-term cancer control.